Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$72.54 - $95.56 $2.61 Million - $3.44 Million
36,021 Added 128.72%
64,004 $6.12 Million
Q4 2023

Feb 02, 2024

BUY
$61.71 - $77.76 $1.73 Million - $2.18 Million
27,983 New
27,983 $2.13 Million
Q1 2023

Apr 27, 2023

BUY
$74.26 - $84.51 $7,426 - $8,451
100 New
100 $8,000
Q1 2022

May 02, 2022

SELL
$101.96 - $128.34 $710,865 - $894,786
-6,972 Closed
0 $0
Q4 2021

Feb 23, 2022

SELL
$106.37 - $130.68 $2.62 Million - $3.22 Million
-24,620 Reduced 77.93%
6,972 $903,000
Q3 2021

Oct 28, 2021

BUY
$102.91 - $122.75 $1.55 Million - $1.85 Million
15,066 Added 91.17%
31,592 $3.31 Million
Q2 2021

Aug 12, 2021

SELL
$83.84 - $104.76 $50,387 - $62,960
-601 Reduced 3.51%
16,526 $1.71 Million
Q1 2021

Apr 26, 2021

SELL
$78.68 - $90.67 $742,581 - $855,743
-9,438 Reduced 35.53%
17,127 $1.43 Million
Q4 2020

Feb 02, 2021

BUY
$71.69 - $91.23 $1.9 Million - $2.42 Million
26,565 New
26,565 $0
Q2 2020

Jul 13, 2020

SELL
$57.54 - $76.95 $584,433 - $781,581
-10,157 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$52.41 - $81.0 $470,746 - $727,542
8,982 Added 764.43%
10,157 $1.92 Million
Q4 2019

Feb 05, 2020

BUY
$71.7 - $82.09 $84,247 - $96,455
1,175 New
1,175 $274,000
Q3 2019

Oct 15, 2019

SELL
$61.55 - $75.43 $87,770 - $107,563
-1,426 Closed
0 $0
Q2 2019

Jul 26, 2019

BUY
$55.74 - $64.41 $79,485 - $91,848
1,426 New
1,426 $263,000
Q4 2018

Jan 16, 2019

SELL
$46.41 - $56.94 $944,397 - $1.16 Million
-20,349 Closed
0 $0
Q3 2018

Oct 23, 2018

SELL
$45.7 - $58.03 $422,953 - $537,067
-9,255 Reduced 31.26%
20,349 $3.54 Million
Q2 2018

Jul 30, 2018

BUY
$42.45 - $51.3 $1.26 Million - $1.52 Million
29,604 New
29,604 $4.31 Million
Q1 2018

Apr 26, 2018

SELL
$37.19 - $47.45 $108,966 - $139,028
-2,930 Closed
0 $0
Q4 2017

Jan 10, 2018

BUY
$33.79 - $39.39 $99,004 - $115,412
2,930
2,930 $330,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.